Global Multi Cancer Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Multi Cancer Screening by Type
  • 1.3.1 Overview: Global Multi Cancer Screening Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Multi Cancer Screening Consumption Value Market Share by Type in 2025
  • 1.3.3 Laboratory Developed Tests (LDTs)
  • 1.3.4 In-Vitro Diagnostics (IVDs)
• 1.4 Global Multi Cancer Screening Market by Application
  • 1.4.1 Overview: Global Multi Cancer Screening Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Hospitals
  • 1.4.3 Clinic
• 1.5 Global Multi Cancer Screening Market Size & Forecast
• 1.6 Global Multi Cancer Screening Market Size and Forecast by Region
  • 1.6.1 Global Multi Cancer Screening Market Size by Region: 2021 VS 2025 VS 2032
  • 1.6.2 Global Multi Cancer Screening Market Size by Region, (2021-2032)
  • 1.6.3 North America Multi Cancer Screening Market Size and Prospect (2021-2032)
  • 1.6.4 Europe Multi Cancer Screening Market Size and Prospect (2021-2032)
  • 1.6.5 Asia-Pacific Multi Cancer Screening Market Size and Prospect (2021-2032)
  • 1.6.6 South America Multi Cancer Screening Market Size and Prospect (2021-2032)
  • 1.6.7 Middle East & Africa Multi Cancer Screening Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Guardant Health
  • 2.1.1 Guardant Health Details
  • 2.1.2 Guardant Health Major Business
  • 2.1.3 Guardant Health Multi Cancer Screening Product and Solutions
  • 2.1.4 Guardant Health Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Guardant Health Recent Developments and Future Plans
• 2.2 GRAIL
  • 2.2.1 GRAIL Details
  • 2.2.2 GRAIL Major Business
  • 2.2.3 GRAIL Multi Cancer Screening Product and Solutions
  • 2.2.4 GRAIL Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 GRAIL Recent Developments and Future Plans
• 2.3 Burning Rock
  • 2.3.1 Burning Rock Details
  • 2.3.2 Burning Rock Major Business
  • 2.3.3 Burning Rock Multi Cancer Screening Product and Solutions
  • 2.3.4 Burning Rock Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Burning Rock Recent Developments and Future Plans
• 2.4 Thermo Fisher Scientific
  • 2.4.1 Thermo Fisher Scientific Details
  • 2.4.2 Thermo Fisher Scientific Major Business
  • 2.4.3 Thermo Fisher Scientific Multi Cancer Screening Product and Solutions
  • 2.4.4 Thermo Fisher Scientific Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.5 Exact Sciences Corporation
  • 2.5.1 Exact Sciences Corporation Details
  • 2.5.2 Exact Sciences Corporation Major Business
  • 2.5.3 Exact Sciences Corporation Multi Cancer Screening Product and Solutions
  • 2.5.4 Exact Sciences Corporation Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Exact Sciences Corporation Recent Developments and Future Plans
• 2.6 Fulgent Genetics
  • 2.6.1 Fulgent Genetics Details
  • 2.6.2 Fulgent Genetics Major Business
  • 2.6.3 Fulgent Genetics Multi Cancer Screening Product and Solutions
  • 2.6.4 Fulgent Genetics Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Fulgent Genetics Recent Developments and Future Plans
• 2.7 Genecast Biotechnology
  • 2.7.1 Genecast Biotechnology Details
  • 2.7.2 Genecast Biotechnology Major Business
  • 2.7.3 Genecast Biotechnology Multi Cancer Screening Product and Solutions
  • 2.7.4 Genecast Biotechnology Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Genecast Biotechnology Recent Developments and Future Plans
• 2.8 Agilent Technologies
  • 2.8.1 Agilent Technologies Details
  • 2.8.2 Agilent Technologies Major Business
  • 2.8.3 Agilent Technologies Multi Cancer Screening Product and Solutions
  • 2.8.4 Agilent Technologies Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Agilent Technologies Recent Developments and Future Plans
• 2.9 Atara Biotherapeutics
  • 2.9.1 Atara Biotherapeutics Details
  • 2.9.2 Atara Biotherapeutics Major Business
  • 2.9.3 Atara Biotherapeutics Multi Cancer Screening Product and Solutions
  • 2.9.4 Atara Biotherapeutics Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Atara Biotherapeutics Recent Developments and Future Plans
• 2.10 Konica Minolta
  • 2.10.1 Konica Minolta Details
  • 2.10.2 Konica Minolta Major Business
  • 2.10.3 Konica Minolta Multi Cancer Screening Product and Solutions
  • 2.10.4 Konica Minolta Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Konica Minolta Recent Developments and Future Plans
• 2.11 Tempus
  • 2.11.1 Tempus Details
  • 2.11.2 Tempus Major Business
  • 2.11.3 Tempus Multi Cancer Screening Product and Solutions
  • 2.11.4 Tempus Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Tempus Recent Developments and Future Plans
• 2.12 Myriad Genetics
  • 2.12.1 Myriad Genetics Details
  • 2.12.2 Myriad Genetics Major Business
  • 2.12.3 Myriad Genetics Multi Cancer Screening Product and Solutions
  • 2.12.4 Myriad Genetics Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Myriad Genetics Recent Developments and Future Plans
• 2.13 Laboratory Corporation
  • 2.13.1 Laboratory Corporation Details
  • 2.13.2 Laboratory Corporation Major Business
  • 2.13.3 Laboratory Corporation Multi Cancer Screening Product and Solutions
  • 2.13.4 Laboratory Corporation Multi Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Laboratory Corporation Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Multi Cancer Screening Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Multi Cancer Screening by Company Revenue
  • 3.2.2 Top 3 Multi Cancer Screening Players Market Share in 2025
  • 3.2.3 Top 6 Multi Cancer Screening Players Market Share in 2025
• 3.3 Multi Cancer Screening Market: Overall Company Footprint Analysis
  • 3.3.1 Multi Cancer Screening Market: Region Footprint
  • 3.3.2 Multi Cancer Screening Market: Company Product Type Footprint
  • 3.3.3 Multi Cancer Screening Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Multi Cancer Screening Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Multi Cancer Screening Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Multi Cancer Screening Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Multi Cancer Screening Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Multi Cancer Screening Consumption Value by Type (2021-2032)
• 6.2 North America Multi Cancer Screening Market Size by Application (2021-2032)
• 6.3 North America Multi Cancer Screening Market Size by Country
  • 6.3.1 North America Multi Cancer Screening Consumption Value by Country (2021-2032)
  • 6.3.2 United States Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Multi Cancer Screening Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Multi Cancer Screening Consumption Value by Type (2021-2032)
• 7.2 Europe Multi Cancer Screening Consumption Value by Application (2021-2032)
• 7.3 Europe Multi Cancer Screening Market Size by Country
  • 7.3.1 Europe Multi Cancer Screening Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 7.3.3 France Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Multi Cancer Screening Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Multi Cancer Screening Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Multi Cancer Screening Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Multi Cancer Screening Market Size by Region
  • 8.3.1 Asia-Pacific Multi Cancer Screening Consumption Value by Region (2021-2032)
  • 8.3.2 China Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 8.3.5 India Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Multi Cancer Screening Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Multi Cancer Screening Consumption Value by Type (2021-2032)
• 9.2 South America Multi Cancer Screening Consumption Value by Application (2021-2032)
• 9.3 South America Multi Cancer Screening Market Size by Country
  • 9.3.1 South America Multi Cancer Screening Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Multi Cancer Screening Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Multi Cancer Screening Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Multi Cancer Screening Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Multi Cancer Screening Market Size by Country
  • 10.3.1 Middle East & Africa Multi Cancer Screening Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Multi Cancer Screening Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Multi Cancer Screening Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Multi Cancer Screening Market Drivers
• 11.2 Multi Cancer Screening Market Restraints
• 11.3 Multi Cancer Screening Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Multi Cancer Screening Industry Chain
• 12.2 Multi Cancer Screening Upstream Analysis
• 12.3 Multi Cancer Screening Midstream Analysis
• 12.4 Multi Cancer Screening Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source